News

  • All
  • Announcements
  • Blog Posts
  • Media Highlights
  • Press Releases

07.21.2021

Absci Announces Pricing of Initial Public Offering

07.07.2021

Absci Strengthens Executive Leadership Team with Strategic Hires to Support Business Growth

06.30.2021

Absci Announces Filing of Registration Statement for Proposed Initial Public Offering

06.17.2021

Contract Pharma: AbSci Acquires Cell Therapy Company Totient

06.14.2021

AbSci Announces Acquisition of Target Discovery Company Totient

06.05.2021

Genetic Engineering & Biotechnology News: Bacterial Platforms Can Rival Mammalian Platforms

04.06.2021

Endpoints News: 20 Under Forty in Biopharma: Sean McClain aims to simplify protein production

03.23.2021

AbSci Announces Completion of $125 Million Crossover Financing to Advance AI-Powered Synthetic Biology Drug Creation Platform

03.23.2021

The Science Advisory Board: AbSci secures $125M in financing

Find out more

Contact Us

Translate ideas into impact

Explore current openings and get ready to prove that impossible isn’t.

Unlimit with us

© Copyright 2021 Absci, Corp